Economics, Econometrics and Finance
4 years ago

Price regulation leads to delays in new drug launches worldwide.

Health Economics
The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s
Patricia M. Danzon, Y. Richard Wang, Liang Wang

Paper Summary

Related papers

Economics, Econometrics and Finance
8 years ago

Monetary Policy Shake-Up: Optimal Inflation Tackles Monopolistic Profits

Macroeconomic Analysis
Monetary Models
Infrastructure Impact
3 views
Economics, Econometrics and Finance
8 years ago

Unemployment could drive down wages and fuel inflation

Macroeconomic Trends
Monetary Models
Macroeconomic Analysis
3 views
Economics, Econometrics and Finance
8 years ago

Nixon's Wage and Price Controls Backfired, Worsening Inflation and Economic Conditions

Macroeconomic Analysis
Macroeconomic Trends
Infrastructure Impact
4 views

Price regulation can delay the launch of new drugs in different countries. A study looked at 85 new drugs launched in 25 major markets in the 1990s. Countries with lower expected prices or smaller markets saw fewer drug launches and longer delays. The US had the most drug launches, followed by Germany and the UK. Countries where drugs could be exported to had negative effects on launches.